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A Developmentally Regulated Switch Directs
Regenerative Growth of Schwann Cells
through Cyclin D1
A logical place to find these practical insights is within
the molecular biology of the Schwann cell cycle. Bas-
erga, Pardee, and others have summarized evidence
that proliferation of mammalian cells is regulated primar-
ily during the G0/G1 phases of the cell cycle (Baserga,
Haesun A. Kim,* Scott L. Pomeroy,²
Wendy Whoriskey,* Inka Pawlitzky,*
Larry I. Benowitz,³ Piotr Sicinski,*
Charles D. Stiles,*§ and Thomas M. Roberts*
*Department of Cancer Biology
Dana-Farber Cancer Institute 1985; Pardee, 1989). Transition through GO/G1 into the S
phase of the cell cycle is regulated by cyclin-dependent²Department of Neurology
Children's Hospital kinases. These cyclin-dependent kinases phosphory-
late retinoblastoma protein (Rb) and other Rb-related³Department of Neurosurgery
Children's Hospital and proteins, such as p107 and p130, leading to the release
of E2F family transcription factors (Grana et al., 1998;Harvard Medical School
Boston, Massachusetts 02115 Mulligan and Jacks, 1998). During transition through G1,
the activity state of cyclin-dependent kinases is regu-
lated by three D-type cyclin proteins that accumulate
in response to growth factor action (reviewed by Sherr,Summary
1994, 1995). Cyclins D1, D2, and D3 share substantial
sequence homology, and they are expressed in an over-Sciatic nerve axons in cyclin D1 knockout mice
lapping fashion in all proliferating tissues (Matsushimedevelop normally, become properly ensheathed by
et al., 1991; Xiong et al., 1992; Sherr, 1994).Schwann cells, and appear to function normally. How-
The structural homology and expression data suggestever, in the Wallerian degeneration model of nerve
that D-type cyclins may be functionally redundant. Thisinjury, the mitotic response of Schwann cells is com-
suggestion is born outÐto a first approximationÐbypletely inhibited. The mitotic block is Schwann cell
targeted gene disruption studies with cyclins D1 andautonomous and developmentally regulated. Rescue
D2. Both cyclin D12/2 and cyclin D22/2 mice are viableanalysis (by ªknockinº of cyclin E) indicates that D1
and relatively normal in phenotype. However, closerprotein, rather than regulatory elements of the D1
scrutiny of cyclin D12/2 and D22/2 mice has revealedgene, provides the essential Schwann cell function.
some tissue-specific functions. For example, in cyclinGenetic inhibition of the Schwann cell cycle shows that
D12/2 mice, retina and mammary epithelium cells showneuronal responses to nerve injury are surprisingly
defects in their proliferation during development. Lossindependent of Schwann cell mitotic responses. Even
of cyclin D2 impairs ovarian granulosa cell and testicularaxonal regrowth into the distal zone of a nerve crush
cell growth (Fantl et al., 1995; Sicinski et al., 1995, 1996).injury is not markedly impaired in cyclin D12/2 mice.
Cyclin D2 knockout mice also show specific defects in
cerebellar histogenesis, including loss of stellate in-Introduction
terneurons and reduced number of granule cells (Huard
et al., 1999).Unlike central nervous system neurons, elements of the
In the studies described here, we show a cyclin-peripheral nervous system can regenerate when dam-
specific phenotype that runs as counterpoint to theaged. The differential response of the central and periph-
examples cited above. During development, D-typeeral nervous systems to injury resides largely within the
cyclins are functionally redundant in control of Schwannproperties of Schwann cells, the glial cells of the periph-
cell growth. However, proliferative growth of matureeral nervous system. Following injury, axons distal to
Schwann cells is strictly dependent upon cyclin D1, boththe injured site degenerate. Myelin sheaths break down
in cell culture and in Wallerian degeneration. Cyclin D1and are phagocytosed by Schwann cells and macro-
knockout mice can thus be used to resolve functionalphages. Collectively, this process is termed Wallerian
relationships between Schwann cell growth and neu-degeneration. Degeneration of the axons and elimina-
ronal components of the response to nerve injury. Ourtion of the myelin sheath are cues for quiescent Schwann
observations on nerve regeneration in cyclin D1 knock-cells distal to the site of damage to divide. Following
out mice indicate that neuronal responses to nerve injurymultiple rounds of replication, new Schwann cells form
are surprisingly independent of Schwann cell growth.guidance tubes that are thought to support the regener-
ation of the axons toward their original targets (Waller,
Results1851; Fawcett and Keynes, 1990). Fundamental insights
into the mechanisms that control Schwann cell growth
Induction of Cyclin D1 and D2, but Not D3, Correlatescould have practical overtones for treatment of periph-
with Growth of Mature Schwann Cells In Vitroeral nerve tumors (Schwann cell hyperplasia) (Riccardi,
The first question we asked was, which of the three1991) and peripheral neuropathies secondary to diabe-
D-type cyclins best correlates with the Schwann celltes, cancer chemotherapeutic agents, toxins, and auto-
growth response? By culturing Schwann cells in plate-immune disorders (Berger and Schaumburg, 1995).
let-derived growth factor± (PDGF-) free medium, we es-
tablished two independent conditions that lead to§ To whom correspondence should be addressed (e-mail: charles_
stiles@dfci.harvard.edu). Schwann cell growth (neuregulin or PDGF 1 forskolin)
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Table 1. In vitro Proliferation (% BrdU Labeling) of Mature
Schwann Cells Isolated from Cyclin D1 and Cyclin D2 Mutant
Micea
Cyclin D1
Growth Factor Experiment 1/1 1/2 2/2
PDGF 1 forskolinb 1 32.8 15.1 6.7
2 22.9 11.3 2.5
Neuregulinc 1 87.7 62.3 15.8
2 84.3 63.6 14.0
3 74.1 61.2 22.7
Cyclin D2
Growth Factor Experiment 1/1 1/2 2/2
PDGF 1 forskolind 1 51.1 60.6 48.3
Neureguline 1 66.5 68.9 54.2
a DRG-derived mouse Schwann cells were expanded in culture and
plated onto poly-L-lysine-coated 8-well glass chamber slides. The
next day, cells were stimulated with either neuregulin (10 ng/ml) or
PDGF (30 ng/ml) 1 forskolin (5 mM) in DMEM-based 5% PPP me-
dium. After immunohistochemistry, the proliferation index was de-
termined as the percentage of Schwann cells that had incorporated
BrdU into the nuclei.
b The % labeled cells compared with wild-type was significantly
decreased in cyclin D1 heterozygous (p 5 0.0118) or homozygous
(p 5 0.0056) mutant mice after stimulation with PDGF 1 forskolin.
c With neuregulin stimulation, the difference between wild-type and
either heterozygous (p 5 0.0005) or homozygous (p , 0.0001) was
significant. The difference between the heterozygous and homozy-
gous mutant cells was also significant (p , 0.0001).
d,e The % labeled cells compared with wild-type was not significantly
different in D21/2 (p 5 0.1935 for neuregulin and p 5 0.05352 for
PDGF 1 forskolin) or D22/2 (p 5 0.0943 for neuregulin and p 5
0.7314 for PDGF 1 forskolin) after stimulation with growth factors.
Significance was determined by paired t test.
Figure 1. Expression of Cyclin D1 and D2, but Not D3, Is Linked to
Mitogenic Stimulus in Schwann Cells
respectively (Figure 1B). As shown in Figure 1C, the(A) Quiescent rat Schwann cells were stimulated in 5% PPP media
with growth factors at the following concentrations: forskolin, 5 mM; tightest correlation for D-type cyclin expression and
PDGF, 30 ng/ml; neuregulin, 10 ng/ml. After 16 hr, [3H]thymidine (5 Schwann cell growth is with cyclins D1 and D2. One of
mCi/ml) was added to the medium, and cells were incubated for an the combinations that leads to Schwann cell growth
additional 30 hr. Incorporation of [3H]thymidine was assayed as (PDGF 1 forskolin) stimulates expression of cyclin D3.
described in the Experimental Procedures as an indicator of the
However, forskolin alone (which does not induce growth)level of DNA synthesis. Each bar represents the mean 6 SD of three
induces cyclin D3 expression. Thus, the induction ofindependent wells in an experiment. Similar results were obtained
in at least five separate experiments. cyclin D3 by the mitogenic combination of PDGF and
(B) Time of S phase entry in Schwann cells stimulated with either forskolin probably reflects the action of forskolin alone.
neuregulin or PDGF 1 forskolin. Amount of DNA synthesis was The correlation between growth and cyclin D1 is further
measured at various times after growth factor stimulation. Arrows strengthened by the observation that nonmitogenic
indicate the time (24 hr after growth factor addition) in S phase at
cues (PDGF or forskolin alone) have little or no effect onwhich lysates were prepared to determine the expression of D-type
cyclin D1 expression. The correlation between growthcyclins. Each error bar represents the mean 6 SD from three inde-
and cyclin D2 is somewhat more tenuous since there ispendent wells.
(C) The expression of cyclin D1, D2, or D3 was assayed in response a significant increase in D2 expression under these same
to mitogenic (neuregulin or PDGF 1 forskolin) or nonmitogenic nonmitogenic conditions.
(PDGF or forskolin) signals. Twenty-four hours after growth factor
stimulation, a time that corresponds to early S phase (indicated
Cyclin D1, but Not D2, Is Necessary for Growthby an arrow in [B]), cell lysates were prepared and analyzed by
of Mature Schwann Cells In Vitroimmunoblotting using cyclin D1, D2, or D3 antibodies. The position
To take the observations in Figure 1 beyond the correla-of each cyclin is indicated by an arrow. Abbreviations: NRG, neureg-
ulin; P 1 F, PDGF 1 forskolin; P, PDGF alone; F, forskolin alone. tive level, primary cultures of Schwann cells were pre-
pared from the dorsal root ganglia (DRG) of embryonic
day 12.5 (E12.5) mouse embryos and matured in culture
and three different conditions that do not lead to (see Experimental Procedures). Analysis of cultures pre-
Schwann cell growth (no addition, forskolin alone, or pared from wild-type, or cyclin D11/2, D12/2, or D22/2,
PDGF alone) (Figure 1A). The lag time between addition mice shows that the growth of mature Schwann cells,
of growth factors and the onset of S phase is z18±20 expanded and isolated in culture, is dependent upon
cyclin D1 (Table 1). This dependence is seen in responsehr for neuregulin and 20±22 hr for PDGF 1 forskolin,
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Figure 2. Schwann Cells Develop Normally in
Mice Lacking Either Cyclin D1 or D2
(A) Myelinated and nonmyelinated axons are
visible in electron micrographs of sciatic
nerve cross sections from 10-week-old wild-
type, and cyclin D1± and D2±deficient, mice.
Note the overall compact appearance of
the myelin sheaths formed by myelinating
Schwann cells (M-SC) and the normal ap-
pearance of nonmyelinating Schwann cells
(NM-SC) ensheathing several small axons in
both the wild-type and mutant sciatic nerves.
Basal laminae (arrowhead) produced by
Schwann cells are also apparent in all ani-
mals. Scale bar, 1 mm.
(B) The number of myelinated and nonmyelin-
ated Schwann cells was determined in the
sciatic nerves of cyclin D1± (10 weeks of age)
or D2± (16 weeks of age) deficient mice and
their wild-type littermates. Ultrathin sections
of sciatic nerves were photographed at
12,0003 magnification, and the number of
myelinated axons was counted (mean 6 SD
from six independent fields from at least two
animals), indicating the number of myelinat-
ing Schwann cells. The number of nonmyelin-
ated Schwann cells was determined by the
number of units of multiple small axons en-
sheathed by a single Schwann cell.
to two independent mitogenic cues (neuregulin and also indicate that neither cyclin D1 nor D2 is specifically re-
quired for proliferation and differentiation of SchwannPDGF 1 forskolin). The effect of cyclin D1 loss on
Schwann cell growth is also gene dose dependent in cells during development. They also suggest that the
loss of one cyclin might be compensated by the pres-that cyclin D11/2 cells exhibited intermediate labeling
between the wild-type and cyclin D12/2 cells. The loss ence of the others during Schwann cell development.
of cyclin D2 does not affect the Schwann cell growth
response. Therefore, cyclin D1, but not D2, is necessary Mature Schwann Cells Require Cyclin D1,
but Not D2, for the Proliferation Responsefor growth of mature Schwann cells in vitro.
to Nerve Injury In Vivo
In an adult animal, Schwann cells remain quiescent un-Schwann Cells Develop Normally in Mice Lacking
Either Cyclin D1 or D2 less their proliferation is induced by nerve injury (Wal-
lerian degeneration). Therefore, we used the nerve injuryThe data in Figure 1 and Table 1 suggest that cyclin
D1±deficient mice should display some peripheral neu- model to assess the function of cyclin D1 and D2 in
mature Schwann cell proliferation in vivo. Sciatic nervesropathy. However, even close scrutiny of the animals
does not reveal any defects in the formation or function of wild-type, and cyclin D11/2, D12/2, and D22/2, mice
were surgically transected to induce Wallerian degener-of Schwann cells in the peripheral nervous system. To
assess the individual contributions of cyclins D1 and D2 ation. One week after the surgery, animals were pulsed
with bromodeoxyuridine (BrdU) to label cells in the DNAto Schwann cell growth and differentiation in vivo, we
examined Schwann cells in the sciatic nerves of mice synthesis phase of the cell cycle. Schwann cells (S1001)
with BrdU-labeled nuclei within the sciatic nerve distalbearing a targeted disruption of either of the two cyclin
genes (Sicinski et al., 1995, 1996). Figure 2A shows elec- to the side of axotomy were identified by immunohisto-
chemistry, as shown in Figure 3A. Quantitative analysistron micrographs of sciatic nerve cross sections from
wild-type and the mutant mice at 10 weeks of age. Quan- of such experiments shows a specific and gene dose-
dependent requirement for cyclin D1 during Walleriantitive analysis of images such as these is summarized
in Figure 2B. In both D12/2 and D22/2 mice, large axons degeneration (Figure 3B). In contrast to the results seen
with cyclin D12/2 mice, regenerative Schwann cellenwrapped by single Schwann cells displayed normal
morphology (compaction of the myelin sheath, number growth in cyclin D22/2 mice is comparable to that seen
in wild-type animals (Figure 3B).of turns around axons of a given size) when compared
with nerves from their wild-type littermates. Nonmy-
elinating Schwann cells (NM-SC), which ensheath multi- Loss of Cyclin D1 Does Not Affect the Growth
of Embryonic Schwann Cells in Cultureple small axons, also appeared normal in both mutant
mice. Basal laminae deposited by Schwann cells were Superficially, the data shown to this point constitute a
paradox. Growth of mature Schwann cells from cyclinvisible in all cases. Neither cyclin D12/2 nor D22/2 ani-
mals show any gross motor or sensory abnormalities D12/2 mice is impaired in culture (Table 1) and in animals
(Figure 3). Yet, the sciatic nerves in cyclin D12/2 mice(i.e., ankle drop, anesthesia) that would suggest a func-
tional defect in the sciatic nerves. These observations form and function normally (Figure 2). This paradox is
Neuron
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Figure 3. In Vivo Schwann Cell Proliferation during Wallerian Degeneration Is Impaired in Mice Lacking Cyclin D1 but Not D2
Sciatic nerves of either wild-type, cyclin D11/2, cyclin D12/2, or cyclin D22/2 mice at 6 weeks of age were surgically transected. One week
after the transection, mice were injected with BrdU, and longitudinal sections of transected distal nerves were prepared and processed for
immunohistochemistry.
(A) Sections were double labeled with a BrdU antibody (green) and an antibody to the Schwann cell marker S100 (red). Schwann cells
undergoing DNA synthesis (S1001/BrdU1) are shown in yellow. Note that the S100 immunostain overlaps BrdU in one of the labeled cells.
This is in accord with other studies showing that S100 immunoreactivity is present in both the cytoplasm and nucleus of Schwann cells in
nerve fibers (Mata et al., 1990).
(B) Quantitation of in vivo Schwann cell proliferation after nerve injury in wild-type, and cyclin D1± and D2±deficient, mice. The number of
S1001/BrdU1 cells/field was counted (mean 6 SEM) in a 403 objective field. In multiple experiments on Schwann cell growth in animals and
in culture, we have seen no evidence of a cyclin D1 or D2 gene dosage effect on the intensity of BrdU staining. Abbreviation: n, number of
fields examined.
reconciled by monitoring the mitogenic response of im- that these are Schwann cells rather than stem cells,
which can also be isolated from rat sciatic nerve at amature Schwann cells derived from embryonic DRG.
As shown in Table 2, there is no significant difference comparable state of development (Morrison et al., 1999).
between the growth of immature Schwann cells isolated
from wild-type and that of cyclin D12/2 mouse embryos. Localization of the Mitotic Defect in Cyclin
D1±Deficient Schwann CellsApparently, within immature Schwann cells, the loss of
cyclin D1 is compensated by the expression of other Where is the lesion in cyclin D12/2 Schwann cells? Do
they express functional growth factor receptors? Is theD-type cyclins functioning in a redundant fashion. As
shown (Figure 4), immature Schwann cells such as those downstream signal transduction apparatus intact? To
answer these questions, we monitored MAP kinase acti-monitored in Table 2 express both p75-NGF receptors
and glial fibrillary acidic protein (GFAP). Coexpression of vation following growth factor stimulation. Binding of
neuregulin or PDGF to its receptors activates the Ras/these Schwann cell±specific marker proteins indicates
Regulation of Schwann Cell Growth by Cyclin D1
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of cyclin D2 within Schwann cells from cyclin D12/2Table 2. In vitro Proliferation (% BrdU Labeling) of Neuron-
Associated Embryonic Schwann Cells Prepared from wild- mice. Schwann cells from wild-type or cyclin D12/2 mice
type and Cyclin D12/2 Mouse Embryos were isolated and stimulated with neuregulin, as de-
scribed for Figure 1. Schwann cell lysates were thenWild-Type Cyclin D12/2
prepared and immunoblotted to monitor the expression
Experiment 1 90.0 92.2
of cyclin D1 and D2. The results (Figure 6) show that80.9
cyclin D2 is responsive to growth factors in D12/2Experiment 2 71.1 73.7
Schwann cells. Thus, the mitotic lesion in cyclin D12/2
Percentage of axon-associated Schwann cells that had incorpo- Schwann cells does not reflect an inability to express
rated BrdU was determined 3 days after DRG were dissociated from
cyclin D2 in response to external, mitogenic cues. NoteE12.5 embryos. Schwann cells were identified by their expression of
also that comparable amounts of cyclin D2 are ex-p75-NGF receptors and the morphological characteristics. In each
experiment, wild-type and cyclin D12/2 cells from littermate embryos pressed in Schwann cells from wild-type and D12/2
were compared. Each data point in an experiment represents the mice. Thus, there is no apparent compensation mecha-
labeling index of Schwann cells derived from a single embryo. nism that leads to overexpression of cyclin D2 in the
absence of D1.
Raf/MAP kinase pathway in Schwann cells (Kim et al.,
Rescue Analysis by ªKnockin Cyclin Eº: The Wallerian
1997a; Rahmatullah et al., 1998). Quiescent wild-type or
Degeneration Phenotype of Cyclin D12/2 Mice
cyclin D12/2 Schwann cells were stimulated with either
Reflects a Selective Requirement
PDGF or neuregulin for 10, 20, or 30 min, then assayed
for Cyclin D1 Protein
for the presence of activated MAP kinases by immuno-
In experiments summarized in Figure 7, we monitored
cytochemistry with phosphopeptide-directed antibodies.
regenerative growth of Schwann cells in a cyclin E!D1
Figure 5 shows double labeling of Schwann cells using
knockin mouse strain. In these mice, the coding se-
antibodies against p75-NGF receptors (red) to mark
quence of the cyclin D1 gene has been deleted and
Schwann cells and activated MAP kinases (green) to
replaced by that of human cyclin E. In the tissues of
display growth factor receptor function. MAP kinase
cyclin E!D1 knockin mice, the expression pattern of
activation is seen as early as 10 min following neuregulin
human cyclin E faithfully mimics that of mouse cyclin
stimulation, both in wild-type and cyclin D12/2 Schwann
D1 (Geng et al., 1999). To an outward appearance, all
cells. The time course of activation is also similar in wild-
of the phenotypic manifestations of cyclin D1 deficiency
type and mutant cells. Comparable results are seen with
(small body size, premature mortality, leg clasping re-
PDGF treatment, although perhaps MAP kinase activa-
flex, etc.) are corrected in the cyclin E!D1 knockin
tion is slightly delayed in cyclin D12/2 cells relative to
strain. Thus, cyclin E protein can functionally compen-
wild-type cells. Interestingly, when visualizing the time
sate for the loss of cyclin D1 protein in most of the
course of MAP kinase activation in wild-type cells, it
tissues that express cyclin D1. However, as shown (Fig-
can be seen that the response to PDGF is somewhat
ure 7), sciatic nerve Schwann cells within the cyclin
retarded relative to that following stimulation with neu-
E!D1 knockin mice nevertheless fail to proliferate in
regulin. The offset in MAP kinase activation kinetics
Wallerian degeneration experiments. Therefore, it is
might explain the delayed S phase entry of PDGF-stimu-
cyclin D1 protein, per se, that is essential in order for
lated Schwann cells relative to those stimulated with
Schwann cell proliferation to proceed normally during
neuregulin (Figure 1B). Taken together, these data show
Wallerian degeneration.
that growth factor receptors are present and functional
in cyclin D12/2 Schwann cells. Thus, the growth defect
in cyclin D12/2 Schwann cells cannot be attributed to Neuronal Components of the Nerve Response
to Injury Do Not Appear to Require Cyclin D1impaired signaling by growth factor receptors.
To further localize the mitotic lesion, we asked We used the cyclin D1 knockout mice to probe for func-
tional relationships between Schwann cell and neuronalwhether growth factors could stimulate the expression
Figure 4. Axon-Associated Immature Schwann Cells from Dissociated DRG Cultures Are Immunoreactive for GFAP
DRG from E12.5±E13 embryos were dissociated and plated in culture as described in Table 2. Three days later, cells were fixed and
immunostained for p75-NGF receptor (red) and GFAP (green). Most of the axon-associated cells were positive for both p75-NGFR and GFAP
(yellow). A very low percentage of p75-NGFR1 cells are negative for GFAP (arrow). Fibroblasts (F) show low background staining for both
antigens. Scale bar, 40 mm.
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Figure 5. Growth Factor Receptors Function Normally in Cyclin D12/2 Schwann Cells
Schwann cells prepared from wild-type or cyclin D12/2 mice were stimulated with either (A) neuregulin (10 ng/ml) or (B) PDGF (30 ng/ml) for
indicated times (10, 20, and 30 min). Cells were then fixed and immunostained for p75-NGF receptor (red), a Schwann cell marker, and
activated MAP kinases (green). MAP kinase activation is seen as early as 10 and 20 min after neuregulin and PDGF stimulation, respectively.
Scale bar, 40 mm.
components of the Wallerian degeneration response. cells are known to express GAP-43 following nerve injury
(Curtis et al., 1992; Plantinga et al., 1993; Scherer et al.,As shown in Figure 8A, axons of wild-type and D12/2
mice degenerate at comparable times downstream (dis- 1994). Second, the tubulin immunostain confirms that
the crush injuries are equivalent in all tested animals.tal) to the point of nerve transection. Upstream (proxi-
mal) to the point of transection, induction of the immedi- Undamaged (old) axons immunostain with tubulin anti-
bodies only, while regrown axons immunostain withate-early gene c-Jun (Leah et al., 1991) is observed at
comparable times in the DRG of wild-type and D12/2 GAP-43 and tubulin antibodies, both. As shown in low-
power images (Figure 9), the amount of GAP-43 immuno-mice (Figure 8B). Thus, these early neuronal responses
to nerve damage are functionally independent of the stain (new axons) is comparable at 1 and 2 weeks post
crush in wild-type and D12/2 mice. Likewise, the numberSchwann cell mitotic response.
We used the GAP-43 antibody to visualize axonal re- of axons that immunostain with bIII-tubulin alone is com-
parable (see overlay images in Figure 9). A higher magni-growth following a nerve crush injury. GAP-43 is ex-
pressed at high levels during axonal growth in develop- fication image of a regenerating sciatic nerve from wild-
type mice is shown in Figure 10. This image showsment or in regeneration (Skene and Willard, 1981a,
1981b; Skene et al., 1986; Schaden et al., 1994). A corre- that the bulk of the GAP-43 immunostain is localized to
axons, although some Schwann cell immunostain canlation between GAP-43 expression and axonal regrowth
in injured sciatic nerves has been demonstrated (Tetzlaff be observed (see Figure 10, overlay).
All mice showed visible signs of paralysis followinget al., 1989; Van der Zee et al., 1989). Double immuno-
staining with antibodies to axon-specific bIII-tubulin the crush. By counting the ratio of GAP-43 axons to
total axons, we could estimate that at least 77% ofserved two purposes. First, the tubulin immunostain
confirms that the bulk of the GAP-43 signal is localized the axons were damaged by the crush procedure, and
possibly more since some damaged axons may not haveto axons. This is an important control since Schwann
Regulation of Schwann Cell Growth by Cyclin D1
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Figure 6. Growth Factor Stimulation Induces Cyclin D2 Expression
in Schwann Cells from Cyclin D12/2 Mice
Schwann cells prepared from wild-type or cyclin D12/2 mice were
stimulated with neuregulin (NRG) (10 ng/ml). Twenty hours later, cell
lysates were prepared and immunoblotted with antibodies to cyclin
D1 and D2. To distinguish the cyclin D2 protein from the D1, total
embryo lysates prepared from wild-type and cyclin D22/2 mice were
used as controls. Cyclin D1 and D2 proteins are marked with arrows.
Lysate from wild-type Schwann cells without neuregulin stimulation
was used as a negative control (first lane). Expression of both cyclin
D1 and D2 protein can be seen in wild-type lysates after neuregulin
stimulation. In cyclin D11/2 cells, the amount of cyclin D1 protein
expression is reduced by half. In both cyclin D11/2 and D12/2 cells,
cyclin D2 protein expression is induced with neuregulin stimulation.
regenerated. As expected, the number of Schwann cells
associated with GAP-43-positive axons in the distal
stump of crushed nerves is significantly reduced in
cyclin D12/2 animals relative to wild-type controls. When
quantitated and normalized to unit length at 1 week post
crush, there are, on average, 2.4 and 1.3 Schwann cells/
axon (140±180 mm in length) in wild-type and cyclin
D12/2 animals, respectively (p , 0.0001). Thus, despite
the inability of Schwann cells to replicate in cyclin D12/2
mice, there is no discernible difference in either the rate
or the extent of axonal regrowth relative to wild-type
Figure 8. Neuronal Responses to Nerve Injury Appear Normal inmice following a nerve crush injury.
Cyclin D12/2 Mice
(A) Wallerian degeneration of the distal nerve occurs normally inDiscussion
cyclin D12/2 mice. Sciatic nerves of wild-type and cyclin D12/2 mice
were surgically transected. One week after axotomy, longitudinal
Only a few tissue-specific functions have been accorded sections of proximal and distal nerves were immunostained for neu-
to specific cyclins. In almost each of these instances, rofilament proteins. In proximal nerves, neurofilament staining is
evident in axons. In both wild-type and cyclin D12/2 mice, neurofila-
ment staining is significantly reduced or appears fragmented
(arrows) in distal nerves, an indication of nerve degeneration; 403
objective field.
(B) c-Jun expression is induced in nerve cell bodies after nerve
injury in both wild-type and cyclin D12/2 mice. Forty-eight hours
after sciatic nerve axotomy, DRG (L4, L5) from the side of injury and
control side (uninjured) of wild-type and cyclin D12/2 mice were
dissected out. Sections were immunostained for c-Jun expression.
In both wild-type and cyclin D12/2 mice, c-Jun expression is only
detected in the neuronal cell bodies of the injured nerves. Scale
bar, 60 mm.
the absence of a particular cyclin leads to highly specific
developmental abnormalities (Sicinski et al., 1995, 1996;
Figure 7. The Schwann Cell Abnormality Is Not Rescued in Cyclin
Huard et al., 1999). Two unexpected findings emergeE!D1 Knockin Mice
from our study on the role of cyclins in Schwann cell
Sciatic nerves of either wild-type, cyclin D12/2, or cyclin E!D1
growth control. The first finding is that cyclin D1 has aknockin (KI) mice were surgically transected. Five days after the
selective function in Schwann cells. The second is thattransection, mice were injected with BrdU, and longitudinal sections
of transected distal nerves were processed for immunohistochemis- this function (or functions) is unmasked in mature
try. Sections were immunostained for BrdU and S100, and the num- Schwann cells and in adult animals rather than in imma-
ber of S1001/BrdU1 cells/field was counted (mean 6 SEM) in a 403 ture Schwann cells and developing animals.
objective field. The number of S1001/BrdU1 cells was significantly Ultrastructural analysis of sciatic nerves indicates that
decreased in D12/2 (p , 0.0001) or E!D1 (KI) (p , 0.0001) mice
cyclin D1 is not required for the initial growth and matu-compared with wild-type. The number of labeled cells was not signif-
ration of Schwann cells. Cyclins D1 and D2 (and per-icantly different between D12/2 and E!D1 (KI) mice (p 5 0.3078).
Abbreviation: n, number of fields examined. haps D3) are functionally redundant within immature
Neuron
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Figure 9. Axonal Regrowth after Nerve Crush in Wild-Type and Cyclin D12/2 Mice
Longitudinal sections of an unlesioned nerve and regenerating nerves 1 week and 2 weeks after nerve crush at 3 mm distal to the crush site.
Sections were double immunostained for GAP-43 (green) and axon-specific bIII-tubulin (red) in order to visualize regrowing axons (yellow).
As expected, most of the axons in unlesioned nerve are GAP-43 negative. One week after crush, the GAP-43 positive axons have appeared
at comparable levels in wild-type and cyclin D12/2 nerves. At 2 weeks post crush, the proportion of new axons has increased, but wild-type
and cyclin D12/2 nerves are still comparable in terms of axonal regrowth. Arrows point to a bundle of small axons that are GAP-43 positive
(see higher magnification image in Figure 10); 203 objective field. Scale bar, 60 mm.
Schwann cells. However, the data in Figure 3 show a D12/2 mice produce functional growth factor recep-
tors. Moreover, growth factors can stimulate expressionspecific requirement for cyclin D1 during Wallerian de-
generation of mature sciatic nerve. This phenotype is of cyclin D2 in these cells. Collectively, these data
show that a developmentally regulated switch channelsSchwann cell autonomous since mature Schwann cells
show a specific growth requirement for cyclin D1 in vitro. growth of mature Schwann cells in culture and regenera-
tive growth in animals selectively through cyclin D1. OurAs shown in Figure 5, mature Schwann cells from cyclin
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Figure 10. Colocalization of GAP-43 Immunostain to Axons Ensheathed by Nonmyelinating Schwann Cells
High magnification image of a crushed nerve section taken from a wild-type mouse at 1 week post crush. Nerve fibers containing small
axons are visible. Axons that show GAP-43 immunoreactivity are also positive for bIII-tubulin staining (see overlay). Some GAP-43-positive
nonmyelinating Schwann cells that lack bIII-tubulin are also visible (arrowheads); 403 objective field.
observations on the cyclin E!D1 knockin mouse (Figure but not in mature Schwann cells. Three potential expla-
nations for the cyclin D1±specific requirement come to7) show that it is cyclin D1 protein, per se, rather than
mind: conceivably, the threshold for cyclin/CDK activityregulatory elements of the cyclin D1 gene, that are re-
required for transit through G1 is reset during the matu-quired in order for Wallerian degeneration to proceed.
ration of Schwann cells to a level that cannot be attainedCyclin D1±deficient mice exhibit a leg clasping pheno-
by the upregulation of cyclin D2 alone. Alternatively, intype (Fantl et al., 1995; Sicinski et al., 1995) similar to
mature Schwann cells, the affinity of CDKs for specificthat observed in a wide range of mice with targeted
D-type cyclins may be modified by interaction with otherdisruptions of genes that are important for neural devel-
protein(s) or by direct phosphorylation of cyclin D/CDKopment (Urbanek et al., 1994). One of these mutants is
complexes. Finally, it is possible that cyclin D1 exertsa mouse with targeted disruption of P0, a Schwann cell
its function in a CDK-independent manner in matureprotein crucial for the myelination of peripheral nervous
Schwann cells and that this CDK-independent func-system axons (Giese et al., 1992). Early on in these stud-
tion cannot be satisfied by other cyclins. The D12/2 Wal-ies, it occurred to us that the leg clasping phenotype in
lerian degeneration phenotype cannot be rescued byD12/2 mice and in P02/2 mice might have common origins
ªknockinº of cyclin E. Since most other phenotypic le-in a myelination defect. However, our data in Figure 2
sions in D12/2 are rescued by cyclin E (Geng et al., 1999),show that Schwann cells develop normally in cyclin
we tend to favor explanations two or three. We noteD12/2 mice, without any obvious myelin defects. There-
that CDK-independent function of cyclin D1 has beenfore, it is unlikely that the leg clasping phenotype exhib-
proposed for other systems (Hirai and Sherr, 1996; Neu-ited in cyclin D12/2 mice is attributed to Schwann cell
man et al., 1997; Inoue and Sherr, 1998; Zwijsen et al.,function. Interestingly enough, the leg clasping pheno-
1998).type is rescued in the cyclin E!D1 knockin mouse (Geng
Cyclin D1 is a proto-oncogene activated via overex-et al., 1999). Thus, this neurological phenotype is clearly
pression in various types of human tumors (Hunter andindependent of the Schwann cell growth defects re-
Pines, 1994). It is not known whether there is a directcorded in this study.
link between aberrant expression of cyclin D1 andOne useful facet of the cyclin D1±specific phenotype
Schwann cell tumorigenesis. However, loss-of-function
is that it allows us to display cause-and-effect relation-
mutations in the neurofibromatosis 1 (NF1) locus have
ships in response to nerve injury. The data summarized
been linked to Schwann cell tumorigenesis in humans
in Figures 8±10 show that early neuronal responses to (Riccardi, 1991). Recent data indicate that Schwann
nerve injury are largely independent of the Schwann cells from NF12/2 mice display constitutively elevated
cell proliferative response. Previous studies have shown levels of cyclin D1 expression relative to those of wild-
that axonal regrowth can occur within sciatic nerves type littermates (data not shown). Thus, NF1 loss-of-
wherein Schwann cells have been removed (Sketelj et function might promote Schwann cell hyperplasia via
al., 1989). These studies thus provide genetic confirma- gratuitous upregulation of cyclin D1 expression.
tion of this earlier work in which Schwann cell participa- The cellular origins of peripheral nerve tumors are
tion in the regenerative response was prevented by still unresolved. Since Schwann cells remain replication
physical means. Further analysis will be required to de- competent throughout adult life, Schwannomas and
termine whether regrown axons can properly remy- neurofibromas might be derived from mature, terminally
elinate in D12/2 mice and whether saltatory conductivity differentiated Schwann cells. Alternatively, these tumors
is restored. Schwann cells also produce trophic factors might originate from early precursor cells via a develop-
that promote nerve cell survival. For this reason, it will mental block. The recent discovery that neural crest±
be important to determine whether newly regenerated derived stem cells persist for extended times through
axons display long-term stability in D12/2 mice. development and can be recovered from fetal sciatic
All D-type cyclins are able to associate with the same nerves (Morrison et al., 1999) lends credence to this
cyclin-dependent kinases (CDKs), CDK4/6 (Sherr, 1994). second scenario. The data presented here suggest one
It is thus unclear why cyclin D2 and/or D3 can compen- possible way to discriminate between these two possi-
bilities, at least for NF1. If hyperplastic Schwann cellssate for the loss of cyclin D1 in immature Schwann cells
Neuron
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incubated for another 24 hr. DNA synthesis was measured by moni-in hereditary neurofibromatosis are derived from mature
toring the incorporation of [3H]thymidine into trichloroacetic acid±Schwann cells, the Schwann cell phenotype of NF1-
insoluble material by liquid scintillation counting as described (Nord-deficient mice would be reduced in a cyclin D1±deficient
lund et al., 1992).
genetic background. For mature mouse Schwann cells, isolated cells that had been
expanded in culture for at least 1 week were plated on poly-L-
lysine-coated 8-well Lab-Tek glass chamber slides (Nalge Nunc,Experimental Procedures
Naperville, IL) in DMEM with 10% FBS at a density of 2.5 3 104
cells/well. The next day, the medium was switched to DMEM withAntibodies
5% PPP with growth factors, and 18 hr later BrdU (6 mg/ml) wasAntibodies to cyclin D1 (72-13G, monoclonal), cyclin D2 (M-30, poly-
added to each well. Twenty-four to twenty-six hours later, cells wereclonal), and cyclin D3 (C-16, polyclonal) were obtained from Santa
fixed in cold methanol and processed for immunostaining. CellsCruz Biotech (Santa Cruz, CA) and used at a dilution of 1:500 in
were incubated with a monoclonal anti-BrdU antibody followed byWestern Blot analysis. For immunofluorescence, the monoclonal
biotinylated secondary antibody according to the manufacturer'santibody to BrdU (Boehringer Mannheim) was used at a dilution of
specifications (Boehringer Mannheim). Immunostaining was visual-1:50. Polyclonal antibody to bovine S100b (Oncogene, Cambridge,
ized with DAB, following instructions of the Vectastain ABC kit (Vec-MA) was used at a dilution of 1:500. Polyclonal antibody to activated
tor Laboratories, Burlingame, CA).MAP kinase (Promega, Madison, WI) was used at a dilution of 1:3000.
Polyclonal antibody to mouse p75-NGF receptor was a gift from Dr.
David Anderson (California Institute of Technology) and was used Embryonic Mouse Schwann Cell Proliferation Assay
at a dilution of 1:200. Polyclonal antibody to GFAP (Sigma) was used DRG from an E12.5 mouse embryo were dissociated and then plated
at a dilution of 1:2000, and a monoclonal antibody to neurofilament onto poly-D-lysine-coated glass coverslips at a density of 1±2 gan-
protein (NF200) (Sigma) was used at a dilution of 1:500. Polyclonal glia/coverslip in DMEM containing 10% horse serum. The next day,
c-Jun antibody (Ab-1) (Oncogene) was used at a dilution of 1:100. the medium was switched to serum-free defined medium (N2), and
A sheep antibody against rat GAP-43 (from Dr. L. Benowitz) was BrdU was added. Two days later, cells were fixed and immuno-
used at a dilution of 1:2500, and a monoclonal antibody against bIII- stained for p75-NGF receptor, a Schwann cell marker, and BrdU. As
tubulin (TUJ1) (Covance, Richmond, CA) was used at a dilution of a proliferation index, the percentage of neuron-associated Schwann
1:500. cells (p75NGFR1) that had incorporated BrdU into the nuclei was
determined.
Primary Rat Schwann Cell Culture
Schwann cells were prepared from sciatic nerves of newborn rats Immunoblotting
(1±2 days old) as described previously. For routine cultures, cells To prepare cell lysates, 90%±95% confluent rat Schwann cells on
were seeded at a density of 106 cells/100 mm poly-L-lysine-coated 60 mm plates were washed twice in phosphate-buffered saline
plate in Dulbecco's modified Eagle's medium (DMEM) with 10% (PBS), then lysed in 300 ml ice-cold lysis buffer (50 mM Tris-HCl [pH
fetal bovine serum (FBS). The medium was changed the next day 7.4], 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM
to DMEM with 10% FBS supplemented with neuregulin (10 ng/ml) EGTA, 10 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM phenylmethylsul-
and forskolin (2 mM). Cells between passages 2 and 4 were used fonyl fluoride, and 0.5 mM sodium orthovanadate). Lysates were
in all experiments described in the text. cleared by centrifugation for 15 min at 14,000 rpm in the cold, and
the protein concentration of the supernatants was determined ac-
cording to manufacturer specifications (Bio-Rad, Hercules, CA). ForPrimary Mouse Schwann Cell Culture
Western blot analysis, 50±70 mg of Schwann cell lysates were sizeMouse Schwann cells were prepared from cyclin D1± or D2±deficient
fractionated on 10% SDS-polyacrylamide gels, transferred ontomouse embryo DRG at E12.5 as described previously, with minor
polyvinylidene difluoride membrane, and immunoblotted with cyclinmodifications (Kim et al., 1997b). Briefly, DRG collected from a single
D1, D2, or D3 antibodies. After incubating with horseradish peroxi-embryo were enzymatically dissociated and plated into two wells
dase±conjugated secondary antibodies, the protein bands were vis-of a 6-well culture plate in DMEM with 10% horse serum supple-
ualized by enhanced chemiluminescence.mented with nerve growth factor (NGF) (50 ng/ml). The genotype of
each embryo was determined by PCR using DNA prepared from
the embryo head as described (Sicinski et al., 1995). The next day, Electron Microscopy
the DRG culture medium was switched to serum-free defined N2 Mice between 10 and 16 weeks of age were sacrificed by intracar-
medium (1:1 ratio of DMEM and F-12, 5 ng/ml Na selenite, 16 mg/ diac perfusion with 4% paraformaldehyde and 2% glutaraldehyde
ml putrescine, 125 ng/ml progesterone, 0.2 mg/ml transferrin, 0.4 in Tris-buffered saline (TBS), and sciatic nerves were dissected and
mg/ml insulin, and 2.5 mg/ml gentamycine) supplemented with NGF postfixed in 2.5% glutaraldehyde for 24 hr. Nerves were cut into 1
(50 ng/ml). Schwann cells remained in direct contact with neurons mm segments and fixed for 1 hr in 1% OsO4 in PBS at room tempera-
for 1 week to allow embryonic Schwann cells to develop into mature ture. After dehydration by an ascending series of alcohol, tissues
Schwann cells. Neurons and Schwann cells were then mechanically were washed in propylene oxide for 15 min, then processed in an
separated from fibroblasts by lifting up neuron layers from the ascending series of Epon medium in propylene oxide. After 24 hr
plates. At this point, cells from the same genotype were pooled, in 100% Epon medium, tissues were embedded for 24 hr at 378C,
and Schwann cells were dissociated from neurons by trituration then for 48 hr at 608C. Ultrathin sections (50 nm in thickness) were
through narrow bored glass pipettes. Dissociated cells were plated then cut using a Sorvall MT5000 ultra-microtome, and the sections
onto poly-L-lysine-coated 60 mm plate in DMEM with 10% FBS at were viewed with a JEOL JEM-100CXII electron microscope.
a density of 106 cells/plate. The next day, cells were switched to N2
medium supplemented with neuregulin (10 ng/ml) and forskolin (2 Nerve Injury
mM). Contaminating neurons were removed from the cultures by Nerve Transection
omitting NGF from the medium. After 7±10 days, the majority of Mice (z20 g) between 6 and 8 weeks of age were anesthetized with
cells (99.5%±99.9%) in the culture were Schwann cells, as distin- tribromoethanol (125±250 mg/kg IP), and incisions were made in
guished by the characteristic morphology and expression of the the upper right thigh to expose the sciatic nerve. The nerve was cut
Schwann cell marker S100. z0.5 cm distal to the sciatic notch, and the wound was closed. The
mice were allowed to recover from surgery. One week after surgery,
animals were injected intraperitoneally with BrdU (50 mg/kg bodySchwann Cell Proliferation Assay
For rat Schwann cells, quiescent cells were plated onto 96-well weight) prepared in PBS. One hour later, the animals were sacrificed
by intracardiac perfusion with 4% paraformaldehyde in TBS (pHculture dishes in DMEM with 10% FBS at a density of 1.5 3 104 cells/
well. Two days after plating, the medium was changed to DMEM with 7.4). Both proximal and distal nerves were harvested and postfixed
in 4% paraformaldehyde for 2 hr, then infused with 30% sucrose5% platelet-poor plasma (PPP) containing growth factors. Eighteen
hours later, [3H]thymidine (5 mCi/well) was added, and cells were overnight at 48C. Tissues were then embedded in Tissue-Tek OCT
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embedding media, and serial 10 mm cryostat sections were cut and Li, T., Weinberg, R.A., and Sicinski, P. (1999). Rescue of cyclin D1
deficiency by knockin cyclin E. Cell 97, 767±777.mounted on coated glass slides.
Nerve Crush Giese, K.P., Martini, R., Lemke, G., Soriano, P., and Schachner, M.
Mice were anesthetized, and sciatic nerves were exposed z0.5 cm (1992). Mouse Po gene disruption leads to hypomyelination, abnor-
distal to the sciatic notch. The nerve was crushed once for 30 s mal expression of recognition molecules, and degeneration of my-
using hemostatic forceps, which yields a lesion 2 mm in length. The elin and axons. Cell 71, 565±576.
crush site was marked by loosely placing a silk suture around the Grana, X., Garriga, J., and Mayol, X. (1998). Role of the retinoblas-
crush lesion, and the wound was closed. Either 7 or 15 days later, toma protein family, pRB, p107 and p130 in the negative control of
a group of mice was sacrificed by cervical dislocation, and both cell growth. Oncogene 17, 3365±3383.
proximal and distal nerves were harvested and fixed by immersing
Hirai, H., and Sherr, C.J. (1996). Interaction of D-type cyclins within 4% paraformaldehyde for 2 hr. Nerves were processed for immu-
a novel myb-like transcription factor, DMP1. Mol. Cell. Biol. 16,nohistochemistry as described for transected nerves.
6457±6467.
Huard, J.M., Forster, C.C., Carter, M.L., Sicinski, P., and Ross, M.E.Immunohistochemistry and Immunocytochemistry
(1999). Cerebellar histogenesis is disturbed in mice lacking cyclinFor BrdU/S100 double immunofluorescence, nerve sections were
D2. Development 126, 1927±1935.fixed in methanol for 10 min at 48C and then processed for immuno-
Hunter, T., and Pines, J. (1994). Cyclins and cancer. II: Cyclin D andstaining with monoclonal antibody against BrdU according to the
CDK inhibitors come of age. Cell 79, 573±582.manufacturer's specifications. Sections were then incubated with
S100b antibody overnight at 48C, washed, and incubated with Cy2- Inoue, K., and Sherr, C.J. (1998). Gene expression and cell cycle
and Cy3-conjugated secondary antibodies. BrdU-S100b double arrest mediated by transcription factor DMP1 is antagonized by
positive cells were viewed by fluorescence optics (Nikon, Japan; D-type cyclins through a cyclin-dependent-kinase-independent
403 objective). For GAP-43/bIII-tubulin immunostaining, sections mechanism. Mol. Cell. Biol. 18, 1590±1600.
were fixed in methanol for 30 min at room temperature and then Kim, H.A., DeClue, J.E., and Ratner, N. (1997a). cAMP-dependent
incubated overnight with sheep anti-GAP-43 antibody in TBS2T (50 protein kinase A is required for Schwann cell growth: interactions
mM Tris-HCl, 1.8% NaCl, 0.1% Tween-20) containing 5% normal between the cAMP and neuregulin/tyrosine kinase pathways. J.
rabbit serum and 2% bovine serum albumin. After three extensive Neurosci. Res. 49, 236±247.
washes in TBS2T, sections were incubated with fluorecein-conju-
Kim, H.A., Ling, B., and Ratner, N. (1997b). Nf1-deficient mousegated rabbit anti-sheep secondary antibody for 1 hr at room temper-
Schwann cells are angiogenic and invasive and can be induced toature. Sections were then blocked in 5% normal goat serum and
hyperproliferate: reversion of some phenotypes by an inhibitor ofincubated with anti-bIII-tubulin antibody (TUJ1) for 1 hr, washed, and
farnesyl protein transferase. Mol. Cell. Biol. 17, 862±872.incubated with Texas red±conjugated goat anti-mouse secondary
Leah, J.D., Herdegen, T., and Bravo, R. (1991). Selective expressionantibody. For cell staining, coverslips were fixed in methanol for 10
of Jun proteins following axotomy and axonal transport block inmin at 2208C, then blocked and permeabilized in 5% normal goat
peripheral nerves in the rat: evidence for a role in the regenerationserum containing 0.1% Triton X-100. For double immunofluores-
process. Brain Res. 566, 198±207.cence (p75-NGFR/activated MAP kinase or p75-NGFR/GFAP), two
primary antibodies were combined and applied to the coverslips. Mata, M., Alessi, D., and Fink, D.J. (1990). S100 is preferentially
Three hours later, coverslips were washed and incubated with Cy2- distributed in myelin-forming Schwann cells. J. Neurocytol. 19,
and Cy3-conjugated secondary antibodies. 432±442.
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